Financial insights of MBRX

MyFinsight

For the quarter ending 2025-09-30.

Unit: Dollar

Income Statement	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenues	0	0	-	-
Research and development	3,738,000	3,600,000	3,435,000	4,353,500
General and administrative	2,147,000	2,091,000	2,477,000	2,275,000
Depreciation and amortization	21,000	29,000	31,000	32,000
Total operating expenses	5,906,000	5,720,000	5,943,000	6,660,500
Loss from operations	-5,906,000	-5,720,000	-5,943,000	-6,660,500
Gain from change in fair value of warrant liability	-1,591,000	-9,609,000	-9,054,000	-3,078,500
Transaction costs allocated to warrant liabilities	530,000	1,207,000	1,788,000	0
Loss on issuance of warrant liabilities	-20,609,000	-10,352,000	-7,798,000	0
Other income, net	16,000	4,000	9,000	11,500
Interest income, net	39,000	26,000	30,000	144,500
Net loss	-25,399,000	-7,640,000	-6,436,000	-3,426,000
Foreign currency translation	-6,000	0	3,000	-27,000
Comprehensive loss	-25,405,000	-7,640,000	-6,433,000	-3,453,000

Net loss per common share - basic and diluted (in dollars per share)	-0.68	-0.49	-0.69	-0.885
Weighted average common shares outstanding, basic and diluted (in shares)	37,304,455	15,526,401	9,343,771	-1,407,262.5